{"id":"https://openalex.org/W2010156563","doi":"https://doi.org/10.1097/00002030-200309050-00020","title":"Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis","display_name":"Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis","alternate_titles":[],"publication_year":2003,"publication_date":"2003-08-27","ids":{"openalex":"https://openalex.org/W2010156563","doi":"https://doi.org/10.1097/00002030-200309050-00020","mag":"2010156563","pmid":"https://pubmed.ncbi.nlm.nih.gov/12960834"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200309050-00020","doi":"https://doi.org/10.1097/00002030-200309050-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200309050-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010156563"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086824050","display_name":"Vincenzo Puro","orcid":"https://orcid.org/0000-0003-0291-4490","observed_orcids":["https://orcid.org/0000-0003-0291-4490"]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vincenzo Puro","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069847014","display_name":"Fabio Soldani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fabio Soldani","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073509656","display_name":"Gabriella De Carli","orcid":"https://orcid.org/0000-0002-3972-8301","observed_orcids":["https://orcid.org/0000-0002-3972-8301"]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriella De Carli","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083116959","display_name":"Zlatan Lazarevic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zlatan Lazarevic","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009871887","display_name":"Francesca Mattioli","orcid":"https://orcid.org/0000-0001-8460-0262","observed_orcids":["https://orcid.org/0000-0001-8460-0262"]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesca Mattioli","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071671768","display_name":"Giuseppe Ippolito","orcid":"https://orcid.org/0000-0002-1076-2979","observed_orcids":["https://orcid.org/0000-0002-1076-2979"]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giuseppe Ippolito","raw_affiliation_strings":["Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Epidemiologia, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210091493"]},{"raw_affiliation_string":"Sponsorship: This study was supported by the Italian Ministry of Health, AIDS Research ISS grant 30D.66, and Ricerca Correrrente IRCCS","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091493"],"apc_list":null,"apc_paid":null,"fwci":1.0965,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.77606162,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"17","issue":"13","first_page":"1988","last_page":"1990"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.18160000443458557,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-post-exposure-prophylaxis","display_name":"HIV post-exposure prophylaxis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.8970000147819519},{"id":"https://openalex.org/keywords/aminotransferase-elevation","display_name":"aminotransferase elevation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9539999961853027},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/liver-function-monitoring","display_name":"liver function monitoring","score":0.7799999713897705},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7789999842643738},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.4959999918937683},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.6611870527267456},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6384665966033936},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6055293679237366},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5445868968963623},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.5068259835243225},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.4841904938220978},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4633949398994446},{"id":"https://openalex.org/C2909254382","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"ANTIRETROVIRAL AGENTS","level":5,"score":0.43702182173728943},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40402305126190186},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.36854618787765503},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.36770543456077576},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.29267072677612305},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2629360854625702},{"id":"https://openalex.org/C2776939746","wikidata":"https://www.wikidata.org/wiki/Q853451","display_name":"Men who have sex with men","level":4,"score":0.0},{"id":"https://openalex.org/C2776983459","wikidata":"https://www.wikidata.org/wiki/Q41083","display_name":"Syphilis","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D017758","descriptor_name":"Infectious Disease Transmission, Patient-to-Professional","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/00002030-200309050-00020","doi":"https://doi.org/10.1097/00002030-200309050-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200309050-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:12960834","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12960834","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unige.it:11567/321893","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11567/321893","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W49694802","https://openalex.org/W108018027","https://openalex.org/W1971648486","https://openalex.org/W1986859702","https://openalex.org/W2073302587","https://openalex.org/W2085691878","https://openalex.org/W2148825772","https://openalex.org/W2331897661","https://openalex.org/W2417342316"],"related_works":["https://openalex.org/W2089350499","https://openalex.org/W4251778779","https://openalex.org/W2414153458","https://openalex.org/W2091653623","https://openalex.org/W15519486","https://openalex.org/W2026660579","https://openalex.org/W2107227728","https://openalex.org/W2028725683","https://openalex.org/W2000797990","https://openalex.org/W2606335749"],"abstract_inverted_index":{"In":[0,137,496,523,609,635,721,910],"655":[1,404],"individuals":[2,164,237,373,419,534,580,807],"receiving":[3,406],"HIV":[4,84,301,407],"postexposure":[5,75],"prophylaxis":[6,76,109,409],"(PEP),":[7],"drug-induced":[8],"aminotransferase":[9,59,259,917],"alterations":[10,776],"were":[11,196,199,265,287,303,327,358,386,429,462,625,664,704,747,764,846],"frequent":[12,121,863],"and":[13,20,25,39,95,147,247,261,277,300,310,317,352,381,399,445,449,452,471,489,565,568,576,605,668,697,766,780,843,864],"severe":[14,865,876],"in":[15,22,31,55,91,161,176,187,289,354,374,378,383,393,403,442,457,519,532,560,571,805,830,848,866,880,889,892,941],"the":[16,56,87,92,124,170,188,273,278,290,306,312,321,324,331,336,348,355,360,366,389,474,493,511,520,614,629,651,716,729,743,797,801,839,872,893,898,907,916,921,932,947,963],"nevirapine-including":[17],"regimen,":[18],"rare":[19,782],"mild-to-moderate":[21],"other":[23,823],"combinations,":[24],"always":[26],"reversible.":[27],"Grade":[28,555],"3\u20134":[29],"incidence":[30,546,674,874],"protease":[32,222],"inhibitor":[33,223],"or":[34,126,227,539,738,749,790],"nevirapine":[35,878,896],"PEP":[36,49,70,135,166,175,208,241,276,370,421,438,515,631,641,690,784,881,935,957],"was":[37,363,439,487,490,530,691,708,757],"0.5":[38,549],"25.0":[40],"per":[41,550,678],"100":[42,551,679],"person-months,":[43],"respectively.":[44,608],"Apart":[45],"from":[46,181,283,320,492,929],"nevirapine,":[47,656],"continuing":[48],"appears":[50,936],"to":[51,83,85,184,205,323,330,627,727,885,937,962],"be":[52,72,861,883,938,959],"safe":[53,939],"even":[54,940],"case":[57,479,942],"of":[58,63,66,89,108,117,128,134,163,172,191,254,257,275,285,308,350,369,413,437,480,501,548,553,599,619,659,676,715,733,742,796,800,841,871,875,906,913,934,943,949,952,966],"alterations.":[60],"The":[61,434,706],"usefulness":[62,948],"routine":[64,950],"monitoring":[65],"liver":[67,155,908,953],"function":[68,954],"during":[69,174,588,783,819,956],"could":[71,826,958],"re-considered.":[73,960],"Antiretroviral":[74,192,414,967],"(PEP)":[77],"is":[78],"widely":[79],"used":[80,334,430],"after":[81,541,596,666,689],"exposures":[82,103],"reduce":[86],"risk":[88],"transmission":[90],"healthcare":[93],"setting,":[94],"it":[96,148],"has":[97],"also":[98],"been":[99,159],"proposed":[100],"for":[101,123,242,248,388,422,464,544,672],"non-occupational":[102],"[1,2].":[104],"This":[105],"large":[106],"use":[107,840,879],"raises":[110],"concerns":[111],"about":[112],"its":[113],"safety.":[114],"Adverse":[115],"events":[116],"antiretroviral":[118,144,400,427,811,834],"drugs":[119,401,717],"are":[120,777,781],"reasons":[122],"discontinuation":[125,284,714],"modification":[127],"therapy":[129,812],"[3,4],":[130],"as":[131,133,391,838,897],"well":[132],"[4,5].":[136],"particular,":[138],"hepatotoxicity":[139,173,815,859],"can":[140,149,860],"occur":[141],"with":[142,484,584,592,602,632,642,710,713,902],"any":[143],"regimen":[145,233,617],"[6],":[146],"complicate":[150],"a":[151,589,711,792,828,903],"hepatic":[152,844],"co-morbidity.":[153],"Furthermore,":[154],"enzyme":[156],"abnormalities":[157],"have":[158],"described":[160,392],"1\u201310%":[162],"taking":[165,535,808],"[4,7,8].":[167],"To":[168],"evaluate":[169],"features":[171],"real":[177],"practice,":[178],"data":[179,856,925],"collected":[180],"August":[182],"1996":[183],"September":[185],"2002":[186],"Italian":[189,411,964],"Registry":[190,412,965],"Post-Exposure":[193,415,968],"Prophylaxis":[194,969],"[4]":[195],"reviewed.":[197],"Subjects":[198],"divided":[200],"into":[201],"three":[202],"groups":[203,443],"according":[204,329],"their":[206,514],"initial":[207,615],"regimen:":[209],"two":[210,218,252,533,583,601,611,633,657,787],"nucleoside":[211],"reverse":[212,230],"transcriptase":[213,231],"inhibitors":[214],"(NRTI)":[215],"(group":[216,225,234],"A),":[217],"NRTI":[219,788],"plus":[220,537,789],"one":[221,228,269,362,694,698],"(PI)":[224],"B),":[226],"non-nucleoside":[229],"inhibitor-containing":[232],"C).":[235],"Only":[236],"who":[238,654,746,761],"had":[239,736],"taken":[240],"at":[243,250,270,305,311,423,431,473,718,752,769],"least":[244,251,424],"5":[245,281],"days,":[246,543,670],"whom":[249],"values":[253,326],"plasma":[255],"level":[256,918],"alanine":[258],"(ALT)":[260],"aspartate":[262],"aminotrasferase":[263],"(AST)":[264],"available":[266],"(the":[267],"first":[268,707],"baseline":[271,322,753],"before":[272],"initiation":[274],"second":[279],"within":[280,507,728,920],"days":[282,441,454,598],"PEP),":[286],"included":[288],"analysis.":[291,495],"Hepatitis":[292],"C":[293,385,483],"virus":[294,298],"(HCV),":[295],"hepatitis":[296,466,482],"B":[297,446,467],"(HBV),":[299],"serology":[302],"performed":[304],"time":[307],"exposure":[309],"6":[313],"month":[314],"follow-up.":[315],"AST":[316,351],"ALT":[318,353],"changes":[319],"highest":[325,361],"categorized":[328],"toxicity":[332],"grading":[333],"by":[335,342],"AIDS":[337],"Clinical":[338],"Trials":[339],"Group,":[340],"modified":[341,613],"Sulkowski":[343],"et":[344],"al.":[345],"[9].":[346],"If":[347],"grades":[349],"same":[356],"determination":[357],"different,":[359],"considered.":[364],"Of":[365,650],"1721":[367],"reports":[368],"analysed,":[371],"207":[372],"group":[375,379,384,458,497,524,636],"A,":[376,498],"429":[377],"B,":[380,525],"19":[382],"eligible":[387],"study,":[390],"Table":[394],"1.Table":[395],"1:":[396],"Baseline":[397],"characteristics":[398],"prescribed":[402],"subjects":[405,461,512,562,612,653,745],"post-exposure":[408],"\u2013":[410],"Prophylaxis,":[416],"1996\u20132002.Overall,":[417],"529":[418],"took":[420,655],"28":[425,669],"days;":[426,509,567],"agents":[428],"standard":[432],"doses.":[433],"median":[435],"duration":[436,799],"30":[440,566],"A":[444],"(range":[447,455],"5\u201360,":[448],"5\u201357,":[450],"respectively),":[451],"25":[453,677],"5\u201332)":[456],"C.":[459,1006,1021,1079,1112,1136],"All":[460],"tested":[463],"HIV,":[465],"serum":[468],"antigen":[469],"(HBsAg),":[470],"HCV":[472,765],"6-month":[475],"follow":[476],"up.":[477],"One":[478,681],"acute":[481],"documented":[485],"seroconversion":[486],"observed":[488,531,665],"excluded":[491],"following":[494],"six":[499,561],"cases":[500,573,639,658,703,760,912],"grade":[502,526,569,585,603,606,620,660,695,699],"1":[503,570,586,700],"AST/ALT":[504,521,528,557,622,648,662,701,724,755,775,914,944],"alteration":[505,529,558,663,702,756,763],"occurred":[506],"10\u201315":[508],"all":[510,722,759,911],"completed":[513,739],"without":[516],"further":[517],"increases":[518],"levels.":[522],"3":[527],"zidovudine\u2013lamivudine":[536],"nelfinavir":[538],"indinavir,":[540],"20":[542,577],"an":[545,643,673],"rate":[547,675],"person-months":[552],"PEP.":[554,740],"2":[556,604,621,696],"developed":[559,647,762],"between":[563,574],"10":[564,575],"eight":[572],"days.":[578],"Four":[579],"discontinued":[581,737],"PEP,":[582],"(one":[587],"hypersensitivity":[590],"reaction":[591],"generalized":[593],"maculopapular":[594],"rash":[595],"7":[597],"treatment),":[600],"3,":[607],"addition,":[610],"PI-containing":[616],"because":[618,795],"alteration,":[623,915],"but":[624],"able":[626],"complete":[628],"4-week":[630],"NRTI.":[634],"C,":[637],"seven":[638],"started":[640],"efavirenz-containing":[644],"regimen;":[645],"none":[646],"alteration.":[649,945],"12":[652],"4":[661],"11":[667],"respectively,":[671],"person-months.":[680],"subject":[682],"required":[683],"hospital":[684],"admission.":[685],"Both":[686],"recovered":[687],"promptly":[688],"stopped.":[692],"Moreover,":[693,822],"observed.":[705],"associated":[709],"rash,":[712],"day":[719],"24.":[720],"groups,":[723],"levels":[725],"returned":[726,919],"normal":[730,922],"range":[731],"regardless":[732],"whether":[734],"they":[735],"Overall,":[741],"16":[744],"anti-HCV":[748],"HBsAg":[750],"positive":[751],"no":[754],"observed;":[758],"HBV":[767],"negative":[768],"baseline.":[770],"Our":[771,852],"study":[772,850,853],"suggests":[773],"that":[774,814,825,858],"often":[778],"mild-to-moderate,":[779],"regimens":[785,868],"including":[786],"minus":[791],"PI,":[793],"probably":[794],"short":[798],"prophylaxis.":[802],"Indeed,":[803],"studies":[804],"HIV-infected":[806],"highly":[809,832,886],"active":[810,833],"demonstrated":[813],"usually":[816],"occurs":[817],"later":[818],"treatment":[820],"[9\u201311].":[821],"factors":[824],"play":[827],"role":[829],"determining":[831],"therapy-associated":[835],"hepatotoxicity,":[836],"such":[837],"ritonavir":[842],"co-morbidity,":[845],"underrepresented":[847],"our":[849],"population.":[851],"confirms":[854],"previous":[855],"showing":[857],"more":[862],"nevirapine-containing":[867,930],"[12].":[869],"Because":[870],"high":[873],"toxicity,":[877],"should":[882],"restricted":[884],"selected":[887],"cases,":[888],"which":[890],"resistance":[891],"source":[894],"indicates":[895],"sole":[899],"possible":[900],"alternative,":[901],"close":[904],"control":[905],"function.":[909],"range.":[923],"These":[924],"suggest":[926],"that,":[927],"apart":[928],"regimens,":[931],"continuation":[933],"Therefore,":[946],"determinations":[951],"tests":[955],"Participants":[961],"D.":[970,979,1071,1082],"Drenaggi,":[971],"Ancona;":[972],"P.":[973,1042,1110,1147],"Rossi,":[974,1140],"Aosta;":[975],"A.":[976,994,1055,1068,1088],"Cellini,":[977],"L'Aquila;":[978],"Tacconi,":[980],"R.":[981],"Maestrini,":[982],"Arezzo;":[983],"F.":[984,1065,1073,1085],"Trifiletti,":[985],"Barcellona":[986],"(ME);":[987],"M.":[988,991,1009,1029,1038,1076,1094,1098,1115,1118,1139],"Monti,":[989],"Bologna;":[990],"Pellegrino,":[992],"Brindisi;":[993],"Stagno,":[995],"Cesena;":[996],"G.":[997,1000,1003,1024,1026,1045,1061,1101,1121,1124,1127,1150],"Vigevani,":[998],"Como;":[999],"Carnevale,":[1001],"Cremona;":[1002],"Raineri,":[1004],"Cuneo;":[1005],"Martinelli,":[1007],"Firenze;":[1008],"Di":[1010],"Toro,":[1011],"Fondi":[1012],"(LT);":[1013],"E.":[1014,1063,1106],"Anzalone,":[1015],"Frosinone;":[1016],"V.":[1017,1032,1108],"Portelli,":[1018],"Erice":[1019],"(TP);":[1020],"Cancellieri,":[1022],"Forli;":[1023],"Cassola,":[1025],"Murdaca,":[1027],"Genova;":[1028],"Baldari,":[1030],"Grosseto;":[1031],"Mercurio,":[1033],"Latina;":[1034],"I.":[1035,1142],"Arcidiacono,":[1036],"Lodi;":[1037],"De":[1039],"Gennaro,":[1040],"Lucca;":[1041],"Castelli,":[1043],"Macerata;":[1044],"Fibbia,":[1046],"Mantova;":[1047],"S.":[1048,1152],"Lagan\u00e0,":[1049],"Massa;":[1050],"O.":[1051],"Renzi,":[1052],"Melegnano":[1053],"(MI);":[1054],"Barelli,":[1056],"Mestre":[1057],"(VE);":[1058],"L.":[1059,1130,1145],"Irato,":[1060],"Micheloni,":[1062],"Iemoli,":[1064],"Niero,":[1066],"Milano;":[1067],"Franco,":[1069],"Napoli;":[1070],"Brustia,":[1072],"Rosa,":[1074],"Novara;":[1075],"Saitta,":[1077],"Palermo;":[1078],"Calzetti,":[1080],"Parma;":[1081],"Francisci,":[1083],"Perugia;":[1084],"Paolillo,":[1086],"Piacenza;":[1087],"Vivarelli,":[1089],"Pistoia;":[1090],"T.":[1091],"Zauli,":[1092],"Ravenna;":[1093],"Massari,":[1095],"Reggio":[1096],"Emilia;":[1097],"Bonaventura,":[1099],"Rieti;":[1100],"Morigi,":[1102],"Rimini;":[1103],"N.":[1104],"Orchi,":[1105],"Nicastri,":[1107],"Galati,":[1109],"Scognamiglio,":[1111],"Del":[1113],"Borgo,":[1114],"Fantoni,":[1116],"Roma;":[1117],"Carretta,":[1119],"Rovigo;":[1120],"Cioffi,":[1122],"Salerno;":[1123],"Ferrea,":[1125],"Sanremo;":[1126],"Calcagno,":[1128],"Savona;":[1129],"Toscano,":[1131],"Siena;":[1132],"B.":[1133],"Salassa,":[1134],"Torino;":[1135,1138],"Gabiano,":[1137],"Treviso;":[1141],"Crosato,":[1143],"Trieste;":[1144],"Panzolli,":[1146],"Viale,":[1148],"Udine;":[1149],"Cristina,Vercelli;":[1151],"Aviani":[1153],"Barbacci,":[1154],"Viterbo.":[1155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010156563","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
